Bryan Dechairo, PhD
Company
Medco Research Institute
Dr. Bryan Dechairo joined Medco in January 2009 as the head of Extramural Research and Development for the Medco Research Institute. In this role, Dr Dechairo translates clinically valid tools into widely accessible and effective medical and pharmacy practice innovations that improve health outcomes for Medco members and decrease the cost of healthcare for Medco clients. Additionally, Dr Dechairo is responsible for business development and strategic alliances which impact Medco’s healthcare innovation pipeline from research through commercial.
Previous to joining Medco, Dr Dechairo was the Neuroscience Lead and Director of Molecular Medicine at Pfizer Global Research and Development, where he led a multi-disciplinary team of scientists and clinicians to deliver novel biomarker driven approaches to drug development. Prior to Pfizer, Dr Dechairo held positions focusing on drug target discovery at Oxagen Ltd and Sequana Therapeutic Inc and on diagnostic development at Roche Molecular Systems and Applied Bio-Division.
Dr Dechairo’s academic career includes a PhD in common complex human genetics from the Institute of Childs Health at the University College of London and a BA in Integrative Biology from the University of California at Berkeley.